SpringWorks Therapeutics, Inc. financial data

Symbol
SWTX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
100 Washington Boulevard, Stamford, Connecticut
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 729 % -42.3%
Debt-to-equity 15 % +18.7%
Return On Assets -48.8 % +1.77%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 74.3M shares +18.7%
Common Stock, Shares, Outstanding 74.3M shares +18.7%
Entity Public Float 1.6B USD +76.6%
Common Stock, Value, Issued 7K USD +16.7%
Weighted Average Number of Shares Outstanding, Basic 74.1M shares +18.7%
Weighted Average Number of Shares Outstanding, Diluted 74.1M shares +18.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 59.7M USD
Research and Development Expense 179M USD +24.9%
General and Administrative Expense 178M USD +47.9%
Costs and Expenses 115M USD +47.9%
Operating Income (Loss) -321M USD -3.4%
Nonoperating Income (Expense) 25.9M USD +50.8%
Net Income (Loss) Attributable to Parent -301M USD -1.06%
Earnings Per Share, Basic -4.44 USD/shares +56.8%
Earnings Per Share, Diluted -4.44 USD/shares +56.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 79.9M USD -30.5%
Marketable Securities, Current 525M USD +94.7%
Cash, Cash Equivalents, and Short-term Investments 522M USD +9.48%
Accounts Receivable, after Allowance for Credit Loss, Current 24.5M USD
Inventory, Net 7.72M USD
Assets, Current 431M USD -10.9%
Property, Plant and Equipment, Net 18.2M USD -0.18%
Operating Lease, Right-of-Use Asset 6.36M USD -5.93%
Other Assets, Noncurrent 15.4M USD +412%
Assets 617M USD +19.3%
Accounts Payable, Current 7.89M USD +128%
Employee-related Liabilities, Current 15M USD +22.6%
Accrued Liabilities, Current 45.7M USD +29.4%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 54.5M USD +30%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 6.1M USD -10.2%
Other Liabilities, Noncurrent 14.7M USD +11091%
Liabilities 60.6M USD -8.02%
Accumulated Other Comprehensive Income (Loss), Net of Tax -520K USD -47.7%
Retained Earnings (Accumulated Deficit) -1.02B USD -41.7%
Stockholders' Equity Attributable to Parent 557M USD +23.3%
Liabilities and Equity 617M USD +19.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -78.9M USD -27.7%
Net Cash Provided by (Used in) Financing Activities -552K USD +70.1%
Net Cash Provided by (Used in) Investing Activities 21.5M USD -78.2%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 74.6M shares +19%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -58M USD -266%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 80.5M USD -30.4%
Deferred Tax Assets, Valuation Allowance 227M USD +44%
Deferred Tax Assets, Gross 230M USD +44.6%
Operating Lease, Liability 7.06M USD +34.4%
Depreciation 253K USD +134%
Payments to Acquire Property, Plant, and Equipment 577K USD -80.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -301M USD -1.62%
Lessee, Operating Lease, Liability, to be Paid 8.03M USD +33.7%
Property, Plant and Equipment, Gross 20.6M USD +39%
Operating Lease, Liability, Current 958K USD +18.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2M USD +73.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.48M USD +88.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +47.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 970K USD +29%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2M USD +69.1%
Deferred Tax Assets, Operating Loss Carryforwards 121M USD +30.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.9M USD +57%
Additional Paid in Capital 1.59B USD +35.2%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 729K USD +188%
Share-based Payment Arrangement, Expense 105M USD +25.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%